HMOX1 and acute myeloid leukemia: This is particularly evident in high-risk groups where elevated HO-1 levels are predictive of poor progression-free survival (PFS), similar to patterns observed in AML where HO-1 is associated with lower overall survival (OS) and relapse-free survival [64].